Venture Management Co. V, L... Net Worth

The estimated Net Worth of Venture Management Co. V, L... is at least $9.47 Milión dollars as of 17 December 2019. Venture L owns over 357,121 units of Phreesia Inc stock worth over $723,270 and over the last 5 years Venture sold PHR stock worth over $8,742,322.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Venture L PHR stock SEC Form 4 insiders trading

Venture has made over 1 trades of the Phreesia Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Venture sold 357,121 units of PHR stock worth $8,742,322 on 17 December 2019.

The largest trade Venture's ever made was selling 357,121 units of Phreesia Inc stock on 17 December 2019 worth over $8,742,322. On average, Venture trades about 357,121 units every 0 days since 2019. As of 17 December 2019 Venture still owns at least 31,015 units of Phreesia Inc stock.

You can see the complete history of Venture L stock trades at the bottom of the page.

Insiders trading at Phreesia Inc

Over the last 5 years, insiders at Phreesia Inc have traded over $277,935,884 worth of Phreesia Inc stock. The most active insiders traders include Edward L Cahill, Venture Partners Ii, L.P.Hl... a Scott Perricelli. On average, Phreesia Inc executives and independent directors trade stock every 8 days with the average trade being worth of $1,320,099. The most recent stock trade was executed by Allison C Hoffman on 26 August 2024, trading 14,110 units of PHR stock currently worth $367,283.

What does Phreesia Inc do?

leading healthcare organizations choose phreesia to revolutionize their point of service. in medical groups of all sizes, phreesia’s flexible and scalable platform drives tangible results across administrative, financial and clinical operations so that staff can focus on providing exceptional patient care.

Complete history of Venture L stock trades at Phreesia Inc

Phreesia Inc executives and stock owners

Phreesia Inc executives and other stock owners filed with the SEC include:

• Chaim Indig,
  Chief Executive Officer, Director
• Evan Roberts,
  Chief Operating Officer
• Thomas Altier,
  Chief Financial Officer
• Chaim Indig,
  Co-Founder, CEO & Director
• David Linetsky,
  Sr. VP of Life Sciences
• Gillian Munson,
  Independent Director
• Cheryl Pegus,
  Independent Director
• Charles Kallenbach,
  General Counsel, Secretary
• Michael Weintraub,
  Independent Chairman of the Board
• Allison C. Hoffman,
  Gen. Counsel & Sec.
• Mark Smith,
  Independent Director
• Edward Cahill,
  Independent Director
• Lainie Goldstein,
  Director
• Dusty Lieb,
  Director
• Balaji Gandhi,
  Vice President - Investor Relations
• Daniel Nathan,
  Chief Technology Officer
• David Linetsky,
  Senior Vice President - Life Sciences
• Amy VanDuyn,
  Senior Vice President - Human Resources
• Michael Davidoff,
  Senior Vice President - Marketing and Business Development
• Randy Rasmussen,
  Chief Accounting Officer
• Amy Beth VanDuyn,
  Sr. VP of HR
• Michael J. Davidoff,
  Sr. VP of Marketing & Bus. Devel.
• Maureen McKinney,
  VP of Corp. Communications
• Daniel Nathan,
  Chief Technology Officer
• Randy Rasmussen,
  Chief Financial Officer
• Ramin Sayar,
  Director
• Venture Partners Ii, L.P.Hl...,
  
• Lisa Egbuonu Davis,
  Director
• Venture Management Co. V, L...,
  
• Scott Perricelli,
  Director
• Capital Iv, Llcllr Equity P...,
  
• Yvonne Hui,
  Principal Accounting Officer
• Allison C Hoffman,
  General Counsel & Secretary
• Janet Gunzburg,
  Principal Accounting Officer